Dmitry Zamansky Sells 5,575 Shares of American Well (NYSE:AMWL) Stock

Key Points

• Insider sale: Dmitry Zamansky sold 5,575 shares on April 1 at an average price of $5.30 for $29,547.50, trimming his stake by 2.26% to 241,080 shares valued at about $1.28 million.
• Quarterly results and outlook: American Well reported Q results with an EPS loss of ($1.52) that beat estimates and revenue of $55.31 million, but it remains unprofitable (negative net margin and ROE) and analysts expect roughly -9.34 EPS for the year.
• Market and analyst view: Shares were up 4.1% to $5.51 (market cap ~$91.1M), and the consensus rating is "Hold" with an average price target of $7.42.

American Well Corporation (NYSE:AMWL - Get Free Report) insider Dmitry Zamansky sold 5,575 shares of the company's stock in a transaction dated Wednesday, April 1st. The shares were sold at an average price of $5.30, for a total transaction of $29,547.50. Following the completion of the sale, the insider directly owned 241,080 shares of the company's stock, valued at $1,277,724. This represents a 2.26% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link.

Dmitry Zamansky also recently made the following trade(s):

• On Friday, January 2nd, Dmitry Zamansky sold 6,243 shares of American Well stock. The stock was sold at an average price of $4.85, for a total transaction of $30,278.55.

American Well Stock Up 4.1%

NYSE:AMWL traded up $0.22 on Thursday, hitting $5.51. The stock had a trading volume of 22,215 shares, compared to its average volume of 92,324. The company has a fifty day moving average price of $5.20 and a two-hundred day moving average price of $5.09. American Well Corporation has a 1-year low of $3.71 and a 1-year high of $9.15. The stock has a market cap of $91.12 million, a price-to-earnings ratio of -0.93 and a beta of 1.34.

American Well (NYSE:AMWL - Get Free Report) last announced its quarterly earnings results on Thursday, February 12th. The company reported ($1.52) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($1.59) by $0.07. American Well had a negative net margin of 38.38% and a negative return on equity of 35.33%. The business had revenue of $55.31 million during the quarter, compared to the consensus estimate of $52.71 million. As a group, analysts anticipate that American Well Corporation will post -9.34 earnings per share for the current year.

Hedge Funds Weigh In On American Well

Several institutional investors have recently bought and sold shares of AMWL. Headlands Technologies LLC purchased a new stake in American Well during the second quarter worth about $39,000. Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in shares of American Well in the third quarter valued at approximately $62,000. Occudo Quantitative Strategies LP purchased a new stake in American Well during the 4th quarter worth approximately $74,000. NewEdge Advisors LLC purchased a new stake in American Well during the 4th quarter worth approximately $82,000. Finally, Prelude Capital Management LLC acquired a new stake in American Well during the 3rd quarter worth approximately $86,000. 56.05% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

AMWL has been the topic of a number of recent analyst reports. Stifel Nicolaus decreased their target price on shares of American Well from $6.00 to $5.00 and set a "hold" rating on the stock in a research report on Friday, February 13th. Wall Street Zen raised shares of American Well from a "sell" rating to a "hold" rating in a research note on Sunday, March 22nd. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of American Well in a research report on Wednesday, January 21st. Finally, Morgan Stanley dropped their target price on shares of American Well from $10.50 to $6.00 and set an "equal weight" rating for the company in a report on Thursday, December 18th. One research analyst has rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and an average price target of $7.42.

American Well Company Profile

American Well, operating under the trade name Amwell, is a Boston-based digital health company that develops and delivers telehealth solutions to healthcare providers, payers, employers and patients. Through its cloud-based platform, the company enables secure virtual visits, remote patient monitoring and integrated care coordination across a range of medical disciplines, including primary care, behavioral health, chronic disease management and urgent care.

The company's core offering, the Amwell Telehealth Platform, facilitates live video consultations, asynchronous messaging, e-prescribing and electronic health record integration.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.